Picture of Avacta logo

AVCT — Avacta Share Price

0.000.00%
gb flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapSucker Stock

Momentum

Relative Strength (%)
1m-29.91%
3m-39.98%
6m-48.86%
1yr-51.7%
Volume Change (%)
10d/3m+117.26%
Price vs... (%)
52w High-73.95%
50d MA-30.65%
200d MA-50.86%

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital-44.57%
Return on Equity-35.39%
Operating Margin-591.39%

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Latest News & Insights for AVCT

Keep an eye on the momentum at Avacta background image

Keep an eye on the momentum at Avacta

Anyone familiar with stock market screeners will know that shares in Avacta (LON:AVCT) have been in an uptrend in recent months, with strong relative price strength on a 1-month, 6-month and 12-month basis.Finding stocks with the poten...

Could Avacta (LON:AVCT) be a turtle trade? background image

Could Avacta (LON:AVCT) be a turtle trade?

Ever since the 1980s, when the now-infamous "Turtle Traders" beat the market with simple strategies based on breakouts to new high prices, momentum investing has been shown to be a potentially profitable strategy.  In fact, many academ...

Breakout Alert: 3 month price surge for Avacta background image

Breakout Alert: 3 month price surge for Avacta

Shares in Avacta (LON:AVCT) have led a strong move away from the market average in recent weeks. On a relative price strength basis, the price is up by 46.3% against the market over the past three months. The last close price was 182p....

Breakout Alert: 3 month price surge for Avacta background image

Breakout Alert: 3 month price surge for Avacta

Shares in Avacta (LON:AVCT) have led a strong move away from the market average in recent weeks. On a relative price strength basis, the price is up by 29.4% against the market over the past three months. The last close price was 157p....

Price Alert: Avacta outperforms over three months background image

Price Alert: Avacta outperforms over three months

Shares in Avacta (LON:AVCT) have performed strongly against the market in recent weeks. On a 3-month relative price strength basis, the price is up by 19.8%. Its last close price was 158p. This kind of outperformance can be driven by a...

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202131st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2021 / 2022

Blurred out image of Avacta EPS forecast chart

Profile Summary

Avacta Group plc is a United Kingdom-based clinical stage biopharmaceutical company. The Company is focused on developing cancer therapies and diagnostics based on its Affimer and prelCISION platforms. The Company operates through three segments: Diagnostics, Therapeutics and Animal Health. Its Diagnostics segment is engaged in the development of custom Affimer proteins for incorporation into customer products and in-house diagnostic assays. Its Therapeutics segment is engaged in the development of cancer immunotherapies combining its platforms. Its Animal Health segment is engaged in the provision of tools and contract services to assist diagnosis of conditions in animals to enable treatment for veterinarians. The Company's diagnostics division is focused on utilizing its Affimer platform to develop AffiDX in vitro diagnostic (IVD) tests, which include AffiDX SARS-CoV-2 Antigen Lateral Flow Test.

Directors

Last Annual
December 31st, 2020
Last Interim
June 30th, 2021
Incorporated
April 29th, 2003
Public Since
September 8th, 2003
No. of Employees
123
Sector
Biotechnology & Medical Research
Industry
Healthcare
Exchange
gb flag iconLondon Stock Exchange
Shares in Issue
273,277,970

AVCT Share Price Performance

Latest News for AVCT

Upcoming Events for AVCT

Full Year 2021 Avacta Group PLC Earnings Release

Avacta Group PLC Annual Shareholders Meeting

Similar to AVCT

Picture of 4Basebio logo

4Basebio

gb flag iconLondon Stock Exchange

Picture of 4d Pharma logo

4d Pharma

gb flag iconLondon Stock Exchange

Picture of Allergy Therapeutics logo

Allergy Therapeutics

gb flag iconLondon Stock Exchange

Arecor Therapeutics

gb flag iconLondon Stock Exchange

Picture of Bioventix logo

Bioventix

gb flag iconLondon Stock Exchange

FAQ

Or unlock with your email

Or unlock with your email